Perrigo Company plc Amortization of Debt Issuance Costs and Discounts
Perrigo Company plc (PRGO) reported Amortization of Debt Issuance Costs and Discounts of -$18.40 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2017-11-09
- Perrigo Company plc amortization of debt issuance costs and discounts for the quarter ending 2017-09-30 was -$6.60M.
- Perrigo Company plc amortization of debt issuance costs and discounts for the quarter ending 2017-07-01 was -$5.40M.
- Perrigo Company plc amortization of debt issuance costs and discounts for the quarter ending 2017-04-01 was -$6.40M.
- Perrigo Company plc amortization of debt issuance costs and discounts for the quarter ending 2016-10-01 was -$8.40M.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|---|---|
| 2017-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$12.00M derived: sum of 2 quarters · filed 2017-11-09 | -$18.40M 10-Q · filed 2017-11-09 |
| 2017-07-01 | -$5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$11.80M 10-Q · filed 2017-08-10 | |
| 2017-04-01 | -$6.40M 10-Q · filed 2017-05-30 | ||
| 2016-10-01 | -$8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$17.90M derived: sum of 2 quarters · filed 2017-11-09 | -$24.60M 10-Q · filed 2017-11-09 |
| 2016-07-02 | -$9.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | -$16.20M 10-Q · filed 2017-08-10 | |
| 2016-04-02 | -$6.70M 10-Q · filed 2017-05-30 | ||
| 2015-09-26 | -$6.70M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-05-23 | -$10.30M derived: sum of 2 quarters · filed 2017-05-23 | -$8.50M 10-Q/A · filed 2017-05-23 |
| 2015-06-27 | -$3.60M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | -$1.80M 10-Q/A · filed 2017-05-22 | |
| 2015-03-28 | $1.80M 10-Q/A · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |